| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $14K | -90.7% |
| SG&A Expense | $1.1M | +96.3% |
| Operating Income | -$1.2M | -57.6% |
| Interest Expense | $120K | -42.9% |
| Income Tax | $0 | — |
| Net Income | -$3.5M | -198.6% |
| EPS (Basic) | -$0.10 | -101.3% |
| EPS (Diluted) | -$0.10 | -126.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $150K | -69.5% |
| Current Assets | $150K | -95.2% |
| Total Assets | $964K | -69.3% |
| Current Liabilities | $3.5M | -68.6% |
| Total Liabilities | $3.5M | -68.6% |
| Stockholders' Equity | -$2.5M | +68.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$582K | -151.1% |
| Investing Cash Flow | -$500K | — |
| Financing Cash Flow | $738K | +3.2% |